首页|Microencapsulated tumor assay: Evaluation of the nude mouse model of pancreatic cancer

Microencapsulated tumor assay: Evaluation of the nude mouse model of pancreatic cancer

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
AIM: To establish a more stable and accurate nude mouse model of pancreatic cancer using cancer cell microencapsulation.METHODS: The assay is based on microencapsulation technology, wherein human tumor cells are encapsulated in small microcapsules (approximately 420 μm in diameter) constructed of semipermeable membranes. We implemented two kinds of subcutaneous implantation models in nude mice using the injection of single tumor cells and encapsulated pancreatic tumor cells. The size of subcutaneously implanted tumors was observed on a weekly basis using two methods, and growth curves were generated from these data. The growth and metastasis of orthotopically injected single tumor cells and encapsulated pancreatic tumor cells were evaluated at four and eight weeks postimplantation by positron emission tomography-computed tomography scan and necropsy. The pancreatic tumor samples obtained from each method were then sent for pathological examination. We evaluated differences in the rates of tumor incidence and the presence of metastasis and variations in tumor volume and tumor weight in the cancer microcapsules vs single-cell suspensions.RESULTS: Sequential in vitro observations of the microcapsules showed that the cancer cells in microcapsules proliferated well and formed spheroids at days 4 to 6. Further in vitro culture resulted in bursting of the membrane of the microcapsules and cells deviated outward and continued to grow in flasks. The optimum injection time was found to be 5 d after tumor encapsulation. In the subcutaneous implantation model, there were no significant differences in terms of tumor volume between the encapsulated pancreatic tumor cells and cells alone and rate of tumor incidence. There was a significant difference in the rate of successful implantation between the cancer cell microencapsulation group and the single tumor-cell suspension group (100% vs 71.43%, respectively, P = 0.0489) in the orthotropic implantation model. The former method displayed an obvious advantage in tumor mass (4th wk: 0.0461 ± 0.0399 vs 0.0313 ± 0.021, t = -0.81, P = 0.4379; 8th wk: 0.1284 ± 0.0284 vs 0.0943 ± 0.0571, t = -2.28, respectively, P = 0.0457) compared with the latter in the orthotopic implantation model.CONCLUSION: Encapsulation of pancreatic tumor cells is a reliable method for establishing a pancreatic tumor animal model.

Nude miceModel of pancreatic neoplasmsEncapsulationSubcutaneous implantation modelOrthotopic implantation model

Ming-Zhe Ma、Dong-Feng Cheng、Jin-Hua Ye、Yong Zhou、Jia-Xiang Wang、Min-Min Shi、Bao-San Han、Cheng-Hong Peng

展开 >

Department of General Surgery, Shanghai Institute of Digestive Surgery, Ruijin Hospital affiliated with to Shanghai JiaoTong University School of Medicine, Shanghai 200025, China

Laboratory Animal Center, Shanghai JiaoTong University School of Medicine, Shanghai 200025, China

Supported by The Scienceand Technology Commission Foun-Science and Technology Commission Foundation of ShanghaiMunicipal Education Commission Foundation of Shanghai

0914090230009YZ84

2012

10.3748/wjg.v18.i3.257

世界胃肠病学杂志(英文版)
太原消化病研治中心

世界胃肠病学杂志(英文版)

SCI
影响因子：1.001
ISSN：1007-9327
年,卷(期)：2012.18(3)
  • 2
  • 29